Agency · +3 more types
“To date, we have supported the development of over 370 health technology assessment (HTA) submission dossiers, including over 135 submission dossiers to NICE, and over 105…”Source: costellomedical.com
Also offers: Health Economic Modeling, Evidence Synthesis & Indirect Comparisons, +2 more
Consulting / Advisory Firm · +2 more types
“Synthesises evidence to support HTA submissions, pricing and reimbursement decisions”Source: openhealthgroup.com
Also offers: RWE for Access & HEOR, Publication Planning & Management, +2 more
Service Provider · +2 more types
Products: D.AI.M.I.
“Build comprehensive, evidence-based submissions tailored to national and regional HTA bodies.”Source: plglifesciences.com
Also offers: Regulatory Development Strategy & Agency Interactions, End-to-End Pharmacovigilance Outsourcing, +5 more
Agency · +3 more types
“We support HTA from start to finish, from access strategy, advisory workshops, submission drafting, modelling, preparation for negotiations and post-submission activities, working…”Source: pharmagenesis.com
Also offers: Publication Planning & Management, Medical Communications Writing, +2 more
Consulting / Advisory Firm · +2 more types
“Handling local HTA and pricing & reimbursement processes, guiding local negotiations”Source: voisinconsulting.com
Also offers: Regulatory Development Strategy & Agency Interactions, Market Access Strategy & Launch Planning, +2 more
Agency · +3 more types
Products: AccessGenius, AccessGenius Insights +9 more
“…We use analytics to define clear access objectives, provide expert advice for Health Technology Assessment (HTA) submissions, and craft customized coding and reimbursement…”Source: precisionaq.com
Also offers: Market Access Strategy & Launch Planning, Key Opinion Leader (KOL) & Stakeholder Engagement, +3 more
CRO / Research Services Provider · +2 more types
Products: InStat, CoAuthor
“Veristat Market Access team members provide strategic advice on national early access programs, write HTA/reimbursement dossiers for submission to national HTA bodies and prepare…”Source: veristat.com
Also offers: Biostatistics & Statistical Programming, Full-Service Clinical Trial Execution (CRO Services), +3 more
Service Provider · +3 more types
Products: TrinityEDGE, InsightsEDGE +6 more
“Support Health Technology Assessments with robust data, global dossiers, and outcomes modeling.”Source: trinitylifesciences.com
Also offers: Market Research & Primary Insights, Product Launch Strategy & Readiness, +2 more
CRO / Research Services Provider · +7 more types
Products: IQVIA Vigilance Platform, SmartSolve +4 more
“Beyond data and insights, work with our local experts to help you manage health technology assessment bodies’ requirements around the world to shorten timeframes and reduce costs…”Source: iqvia.com
Also offers: Full-Service Clinical Trial Execution (CRO Services), Real-World Data Platform, +6 more
Consulting / Advisory Firm · +4 more types
Products: Lumanity Illuminator, Evidence Illuminator +9 more
“With a proven track record of success in HTA, including to bodies such as the National Institute for Health and Care Excellence (NICE), Institute for Clinical and Economic Review…”Source: lumanity.com
Also offers: Market Access Strategy & Launch Planning, Brand Strategy & Positioning, +2 more
What this covers: Strategic, technical, and writing support for health technology assessment submissions and reimbursement submissions to HTA bodies.
| Vendor | Delivery model | Also offers | In their words |
|---|---|---|---|
| Costello Medical | Agency | HEOR Strategy & Evidence Planning, Health Economic Modeling, Outcomes Research & Burden of Illness, Evidence Synthesis & Indirect Comparisons, RWE for Access & HEOR | “To date, we have supported the development of over 370 health technology assessment (HTA) submission dossiers, including over 135 submission dossiers to NICE…”costellomedical.com · reviewed Oct 21, 2026 |
| IQVIA | CRO / Research Services Provider | HEOR Strategy & Evidence Planning, Health Economic Modeling, Outcomes Research & Burden of Illness, Evidence Synthesis & Indirect Comparisons, RWE for Access & HEOR | “Beyond data and insights, work with our local experts to help you manage health technology assessment bodies’ requirements around the world to shorten…”iqvia.com · reviewed Oct 19, 2026 |
| Lumanity | Consulting / Advisory Firm | HEOR Strategy & Evidence Planning, Health Economic Modeling, Outcomes Research & Burden of Illness, Evidence Synthesis & Indirect Comparisons, RWE for Access & HEOR | “With a proven track record of success in HTA, including to bodies such as the National Institute for Health and Care Excellence (NICE), Institute for Clinical…”lumanity.com · reviewed Oct 21, 2026 |
| OPEN Health | Consulting / Advisory Firm | HEOR Strategy & Evidence Planning, Health Economic Modeling, Outcomes Research & Burden of Illness, Evidence Synthesis & Indirect Comparisons, RWE for Access & HEOR | “Synthesises evidence to support HTA submissions, pricing and reimbursement decisions”openhealthgroup.com · reviewed Oct 20, 2026 |
| Oxford PharmaGenesis | Agency | HEOR Strategy & Evidence Planning, Health Economic Modeling, Outcomes Research & Burden of Illness, Evidence Synthesis & Indirect Comparisons, RWE for Access & HEOR | “We support HTA from start to finish, from access strategy, advisory workshops, submission drafting, modelling, preparation for negotiations and post-submission…”pharmagenesis.com · reviewed Oct 20, 2026 |
| Precision AQ | Agency | HEOR Strategy & Evidence Planning, Health Economic Modeling, Outcomes Research & Burden of Illness, Evidence Synthesis & Indirect Comparisons, RWE for Access & HEOR | “…We use analytics to define clear access objectives, provide expert advice for Health Technology Assessment (HTA) submissions, and craft customized coding and…”precisionaq.com · reviewed Oct 28, 2026 |
| ProductLife Group | Service Provider | HEOR Strategy & Evidence Planning, Health Economic Modeling, Outcomes Research & Burden of Illness, RWE for Access & HEOR | “Build comprehensive, evidence-based submissions tailored to national and regional HTA bodies.”plglifesciences.com · reviewed Oct 26, 2026 |
| Trinity Life Sciences | Service Provider | HEOR Strategy & Evidence Planning, Health Economic Modeling, Outcomes Research & Burden of Illness, Evidence Synthesis & Indirect Comparisons, RWE for Access & HEOR | “Support Health Technology Assessments with robust data, global dossiers, and outcomes modeling.”trinitylifesciences.com · reviewed Oct 21, 2026 |
| Veristat | CRO / Research Services Provider | — | “Veristat Market Access team members provide strategic advice on national early access programs, write HTA/reimbursement dossiers for submission to national HTA…”veristat.com · reviewed Oct 26, 2026 |
| Voisin Consulting Life Sciences | Consulting / Advisory Firm | HEOR Strategy & Evidence Planning, Health Economic Modeling, Outcomes Research & Burden of Illness, Evidence Synthesis & Indirect Comparisons, RWE for Access & HEOR | “Handling local HTA and pricing & reimbursement processes, guiding local negotiations”voisinconsulting.com · reviewed Oct 20, 2026 |